BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37197952)

  • 1. Gaps in the Care of Subjects with Familial Hypercholesterolemia: Insights from the Thai Familial Hypercholesterolemia Registry.
    Ganokroj P; Muanpetch S; Deerochanawong C; Phimphilai M; Leelawattana R; Thongtang N; Krittayaphong R; Anthanont P; Vathesatogkit P; Sriphrapradang C; Senthong V; Torpongpun A; Suteerayongprasert P; Pengpong N; Sathavarodom N; Sunanta U; Porntharukchareon T; Kiatpanabhikul P; Kaewkrasaesin C; Suraamornkul S; Kongkit J; Umphonsathien M; Chattranukulchai P; Jiamjarasrungsi W; Khovidhunkit W
    J Atheroscler Thromb; 2023 Dec; 30(12):1803-1816. PubMed ID: 37197952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
    Rizos CV; Elisaf MS; Skoumas I; Tziomalos K; Kotsis V; Rallidis L; Garoufi A; Athyros VG; Skalidis E; Kolovou G; Koutagiar I; Papagianni M; Antza C; Katsiki N; Ganotakis E; Liberopoulos EN
    Atherosclerosis; 2018 Oct; 277():308-313. PubMed ID: 30270064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latvian registry of familial hypercholesterolemia: The first report of three-year results.
    Latkovskis G; Saripo V; Gilis D; Nesterovics G; Upena-Roze A; Erglis A
    Atherosclerosis; 2018 Oct; 277():347-354. PubMed ID: 30270070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease.
    De Luca L; Arca M; Temporelli PL; Colivicchi F; Gonzini L; Lucci D; Bosco B; Callerame M; Lettica GV; Di Lenarda A; Gulizia MM;
    Clin Cardiol; 2018 Aug; 41(8):1075-1083. PubMed ID: 30039543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.
    Perez de Isla L; Alonso R; Watts GF; Mata N; Saltijeral Cerezo A; Muñiz O; Fuentes F; Diaz-Diaz JL; de Andrés R; Zambón D; Rubio-Marin P; Barba-Romero MA; Saenz P; Sanchez Muñoz-Torrero JF; Martinez-Faedo C; Miramontes-Gonzalez JP; Badimón L; Mata P;
    J Am Coll Cardiol; 2016 Mar; 67(11):1278-85. PubMed ID: 26988947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry.
    Saltijeral A; Pérez de Isla L; Alonso R; Muñiz O; Díaz-Díaz JL; Fuentes F; Mata N; de Andrés R; Díaz-Soto G; Pastor J; Pinilla JM; Zambón D; Pinto X; Badimón L; Mata P;
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):444-450. PubMed ID: 27913073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry.
    Schmidt N; Dressel A; Grammer TB; Gouni-Berthold I; Julius U; Kassner U; Klose G; König C; Koenig W; Otte B; Parhofer KG; Reinhard W; Schatz U; Schunkert H; Steinhagen-Thiessen E; Vogt A; Laufs U; März W
    Atherosclerosis; 2018 Oct; 277():314-322. PubMed ID: 30270065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL-cholesterol goal achievement, cardiovascular disease, and attributed risk of Lp(a) in a large cohort of predominantly genetically verified familial hypercholesterolemia.
    Bogsrud MP; Græsdal A; Johansen D; Langslet G; Hovland A; Arnesen KE; Mundal LJ; Retterstøl K; Wium C; Holven KB
    J Clin Lipidol; 2019; 13(2):279-286. PubMed ID: 30910667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence and treatment patterns of familial hypercholesterolemia among Thai patients with premature coronary artery disease.
    Nawaka N; Rattanawan C; Pussadhamma B; Wutthimanop A; Nuinoon M; Porntadavity S; Theansun W; Jeenduang N
    Postgrad Med; 2023 May; 135(4):410-417. PubMed ID: 36803651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry.
    Amrock SM; Duell PB; Knickelbine T; Martin SS; O'Brien EC; Watson KE; Mitri J; Kindt I; Shrader P; Baum SJ; Hemphill LC; Ahmed CD; Andersen RL; Kullo IJ; McCann D; Larry JA; Murray MF; Fishberg R; Guyton JR; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Underberg JA; Thompson P; Duffy D; Linton MF; Shapiro MD; Moriarty PM; Knowles JW; Ahmad ZS
    Atherosclerosis; 2017 Dec; 267():19-26. PubMed ID: 29080546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.
    Duell PB; Gidding SS; Andersen RL; Knickelbine T; Anderson L; Gianos E; Shrader P; Kindt I; O'Brien EC; McCann D; Hemphill LC; Ahmed CD; Martin SS; Larry JA; Ahmad ZS; Kullo IJ; Underberg JA; Guyton J; Thompson P; Wilemon K; Roe MT; Rader DJ; Cuchel M; Linton MF; Shapiro MD; Moriarty PM; Knowles JW
    Atherosclerosis; 2019 Oct; 289():85-93. PubMed ID: 31487564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attainment of Low-Density Lipoprotein Cholesterol Targets and Prescribing Pattern of Lipid-Lowering Medications among Patients with Familial Hypercholesterolemia Attending Specialist Clinics.
    Chua YA; Nazli SA; Rosman A; Kasim SS; Ibrahim KS; Md Radzi AB; Mohd Kasim NA; Nawawi H
    J Atheroscler Thromb; 2023 Oct; 30(10):1317-1326. PubMed ID: 36567112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Search for familial hypercholesterolemia patients in an Italian community: A real-life retrospective study.
    Fasano T; Trenti C; Negri EA; Guiducci V; Foracchia M; Bonelli E; Canovi S; Besutti G; Bertolini S; Calandra S
    Nutr Metab Cardiovasc Dis; 2022 Mar; 32(3):577-585. PubMed ID: 35123858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
    Yamashita S; Masuda D; Harada-Shiba M; Arai H; Bujo H; Ishibashi S; Daida H; Koga N; Oikawa S
    J Atheroscler Thromb; 2022 May; 29(5):608-638. PubMed ID: 33980760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry.
    Vrablik M; Raslová K; Vohnout B; Blaha V; Satny M; Kyselak O; Vaclova M; Urbanek R; Maskova J; Soska V; Freiberger T
    Atherosclerosis; 2018 Oct; 277():355-361. PubMed ID: 30270071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Awareness, treatment rates, and compliance to treatment in patients with serum LDL cholesterol higher than 250 mg/dL, and possible, probable, or definite familial hypercholesterolemia.
    Yaman S; Ozdemir D; Akman BT; Cakir B; Ersoy O
    Postgrad Med; 2021 Mar; 133(2):146-153. PubMed ID: 32744105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction.
    Singh A; Gupta A; Collins BL; Qamar A; Monda KL; Biery D; Lopez JAG; de Ferranti SD; Plutzky J; Cannon CP; Januzzi JL; Di Carli MF; Nasir K; Bhatt DL; Blankstein R
    J Am Coll Cardiol; 2019 May; 73(19):2439-2450. PubMed ID: 31097165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficiency and problems of statin therapy in patients with heterozygous familial hypercholesterolemia.
    Korneva V; Kuznetsova T; Julius U
    Atheroscler Suppl; 2019 Dec; 40():79-87. PubMed ID: 31818452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-density lipoprotein cholesterol goal attainment in patients with clinical evidence of familial hypercholesterolemia and elevated Lp(a).
    Schwarz A; Demuth I; Landmesser U; Haghikia A; König M; Steinhagen-Thiessen E
    Lipids Health Dis; 2022 Nov; 21(1):114. PubMed ID: 36324160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.